Utama › Limfoma Burkitt › Michigan › Grand Rapids

Kajian klinikal Limfoma Burkitt di Grand Rapids, MI

7 kajian untuk Limfoma Burkitt sedang mencari peserta di lokasi dalam dan sekitar Grand Rapids (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Mengambil pesertaFasa 2

Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids

366 Days – 46 Years · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Mengambil pesertaFasa 3

Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids

Umur 18 hingga 39 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT03150693

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Mengambil pesertaFasa 2

Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids

365 Days · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06317662

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Mengambil pesertaFasa 1/2

Corewell Health ( Site 1001), Grand Rapids

6 Months – 25 Years · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06395103

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Mengambil pesertaFasa 2

Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids

Umur 1 hingga 30 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Mengambil pesertaFasa 3

Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids

365 Days – 25 Years · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT03959085

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Mengambil pesertaFasa 2

Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids

Umur 1 hingga 25 · Semua jantina · Dikemas kini 4 Mei 2025 · NCT03509961

Kajian Limfoma Burkitt di bandar lain

Kajian lain di Grand Rapids

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.